[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Quick Uptakes
March 22/29, 2000

New Guidance on PSA Testing

Author Affiliations
 

Not Available

Not Available

JAMA. 2000;283(12):1557. doi:10.1001/jama.283.12.1557

A new policy report from the American Urological Association (AUA) advises physicians on the best use of prostate-specific antigen (PSA) testing in the diagnosis and management of prostate cancer.

"The report cuts to the quick of what we actually know about the PSA test, thereby helping to eliminate many commonly performed procedures used to diagnose, stage, and monitor prostate cancer," said Ian Thompson, MD, of the University of Texas, San Antonio, Medical Center, and chair of the AUA committee that developed the policy.

First Page Preview View Large
First page PDF preview
First page PDF preview
×